Would of loved it at the break out price of $8.25 back in March of this year, but just off the year high at $18ish?
Not so sure. Bios have gone nuts, but I'm scared the party could be coming to an end. DRTX doing well
thanks...but I think you have it wrong....it will be acquired....orphan drug...no competition worldwide...rights theirs worldwide....drug sells for 300.000 per patient....110.000.000 at least per year in royalties for many years to come from other collaborations from different drugs....they had another succesfull phase 3 for another indication with approval coming this year....50 bucks I see soon and then more if not get bought.